NCT01613183 is a NA clinical trial of Chinese herbal Medicine in Primary Insomnia, sponsored by China Academy of Chinese Medical Sciences.

Who is sponsoring NCT01613183?

NCT01613183 is sponsored by China Academy of Chinese Medical Sciences.

What drugs are being tested in NCT01613183?

Interventions in NCT01613183: Chinese herbal Medicine, the dummy of a Chinese Medicine prescription.

What condition does NCT01613183 study?

NCT01613183 studies Primary Insomnia.

Is NCT01613183 still recruiting?

NCT01613183 is currently status unknown. Last updated 4 June 2012.

Last reviewed 2012-06-04 · How we verify

NCT01613183

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia

Status unknown NA Last updated 4 June 2012

What this trial tests

NA trial testing Chinese herbal Medicine in Primary Insomnia in 2 participants. Status unknown.

Timeline

1 May 2012

Quick facts

Lead sponsor	China Academy of Chinese Medical Sciences
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	2
Start date	1 May 2012
Sites	1 location across China

Drugs / interventions tested

Chinese herbal Medicine
the dummy of a Chinese Medicine prescription

Conditions studied

Primary Insomnia — all drugs for Primary Insomnia →

Sponsor

China Academy of Chinese Medical Sciences — full company profile →

Who can join

Adults 18 to 65, any sex, with Primary Insomnia. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

change from baseline in Total Sleep Time (TST) at 4 weeks
Time frame: baseline and 4 weeks

Sponsor's own description

The objective of this study is to screen the effective core formulation in insomnia treatment with Chinese medicine with a double-blind, randomized, placebo-controlled trial.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Exploring effective core drug patterns in primary insomnia treatment with Chinese herbal medicine: study protocol for a randomized controlled trial.
Yan S, Zhang R, Zhou X, Li P, et al · · 2013 · cited 11× · PMID 23448313 · DOI 10.1186/1745-6215-14-61
Publication of Results of Registered Trials With Published Study Protocols, 2011-2022.
Vorland CJ, Brown AW, Kilicoglu H, Ying X, et al · · 2024 · cited 10× · PMID 38190185 · DOI 10.1001/jamanetworkopen.2023.50688
Efficacy of Chinese Medicine Treatment Based on Syndrome Differentiation for Primary Insomnia: A Randomized Placebo Controlled Triple-Blinded Trial.
Xiong ZY, Lu Y, He LY, Zhang RS, et al · · 2024 · cited 3× · PMID 38753273 · DOI 10.1007/s11655-024-3661-4

Verify or expand the search:

Other recruiting trials for Primary Insomnia

Currently open trials in the same condition.

NCT06996171 — Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia · NA · recruiting
NCT06782815 — Acupoint Selection Based on Meridian Theory in Primary Insomnia of Liver Depression and Spleen Deficiency Type · NA · recruiting
NCT05830877 — The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia · NA · recruiting

Other China Academy of Chinese Medical Sciences trials

Trials by the same sponsor.

NCT07319338 — Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis · not yet recruiting
NCT06874738 — A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills · not yet recruiting
NCT05586048 — Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure · unknown
NCT05138965 — the Method of Cotton Padding Promoting the Rectovaginal Fistula Surgery · completed
NCT04932395 — Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis · Phase 4 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01613183 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by China Academy of Chinese Medical Sciences
Last refreshed: 4 June 2012

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01613183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing